News from csl A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

Apr 23, 2015, 09:07 ET
CSL Behring logo

CSL Behring Awards Young Researchers Around the World to Advance Coagulation Science

CSL Behring Professor Heimburger Award Provides 100,000 Euros in Start-Up Grants to Emerging Coagulation Investigators; Underscores CSL...

Apr 14, 2015, 09:30 ET
World Federation of Hemophilia Logo

CSL Behring Marks World Hemophilia Day by Renewing Pledge to World Federation of Hemophilia

CSL Behring to Donate 10 Million IUs of its Bleeding Disorder Protein Therapies and to Contribute More than $1.1 Million in Financial Support to...

Mar 30, 2015, 08:58 ET
CSL Behring logo.

European Medicines Agency Commences Review of CSL Behring's Regulatory Submission for rIX-FP for Hemophilia B Patients

rIX-FP Regulatory Submissions Now Made in EU and U.S.; Underscores CSL Behring's Legacy of Improving the Care for Patients with Bleeding...

Mar 17, 2015, 09:00 ET

The Lancet Publishes CSL Behring's Kcentra® Phase III Data

CSL Behring today announced that The Lancet has published results from a Phase III clinical study showing Kcentra® (Prothrombin Complex...

Mar 09, 2015, 09:00 ET
CSL Behring employees take time out from their work day to package clothes, shoes, books, toys, baby safety equipment and school supplies for thousands of children in the Philadelphia area as part of the Cradles to Crayons program. Cradles to Crayons is one of many charitable programs supported by CSL Behring and its employees throughout the year.

CSL Behring to Provide $80,000 in Scholarship Funding For Low-Income Students in Philadelphia Area

CSL Behring announced that it is partnering with Children's Scholarship Fund Philadelphia (CSFP) to support scholarships for low-income students....

Feb 27, 2015, 09:00 ET
CSL Behring logo

CSL Behring Continues Treatment Access Leadership by Donating Bleeding Disorder Protein Therapies IUs to World Federation of Hemophilia

 In recognition of Rare Disease Day and as part of its ongoing commitment to the global bleeding disorders community, CSL Behring announced...

Feb 19, 2015, 15:35 ET

Canada Steamship Lines Wins 2015 Lloyd's List Inland/Coastal/Lakes Operator of the Year Award

MONTREAL, Feb. 19, 2015 /PRNewswire/ - Canada Steamship Lines was recognized last evening as one of "the best and brightest in North American...

Feb 13, 2015, 11:02 ET

CSL Completes Historic Trillium Newbuild Program with Arrival of CSL St-Laurent in Montreal

MONTREAL, Feb. 13, 2015 /CNW Telbec/ - The last of Canada Steamship Lines' six Trillium Class Great Lakes vessels, the 36,363 DWT bulk carrier...

Feb 04, 2015, 11:00 ET
CSL Behring logo

U.S. FDA Accepts for Review CSL Behring's Biologics License Application for rIX-FP for Hemophilia B Patients

CSL Behring Achieves Another Key Milestone in PROLONG-9FP, its Recombinant Factor IX Fusion Protein Development Program; Continues to Advance CSL...

Feb 02, 2015, 09:00 ET

FDA Approves New Dosing Option for CSL Behring's Hizentra®

 CSL Behring announced today that the U.S. Food and Drug Administration (FDA) has expanded the administration options...

Jan 06, 2015, 09:40 ET

MV CSL Welland arrives in Port of Montreal, completing maiden voyage

MONTREAL, Jan. 6, 2015 /CNW Telbec/ - Canada Steamship Lines welcomed CSL Welland, the latest addition to its Trillium Class fleet on the...

Dec 22, 2014, 13:30 ET
Dec 16, 2014, 13:24 ET

CSL St-Laurent Sets Sail on Maiden Voyage, Completing CSL's Trillium Class Newbuild Program

MONTREAL, Dec. 16, 2014 /CNW Telbec/ - The second of Canada Steamship Lines' (CSL) two newbuild Trillium Class Great Lakes bulk carriers, CSL...

Dec 16, 2014, 09:04 ET
CSL Behring logo.

CSL Behring Submits Biologics License Application for FDA Approval of Recombinant Fusion Protein Linking Coagulation Factor IX with Recombinant Albumin (rIX-FP) for Hemophilia B Patients

CSL Behring Continues Improving Patient Well-Being; Key Milestone Achieved in PROLONG-9FP, Company's Recombinant Factor IX Fusion Protein...

Dec 04, 2014, 09:00 ET
CSL Behring logo.

CSL Issues "Our Corporate Responsibility 2014" Report

CSL Behring's parent company CSL Limited (ASX: CSL) has issued its annual corporate responsibility report – "Our Corporate Responsibility...

Dec 04, 2014, 06:00 ET

La EMA aprueba la ficha técnica enmendada de Hizentra® de CSL Behring

-- La nueva ficha técnica ofrece una mayor flexibilidad y capacidad para personalizar la dosificación CSL Behring ha...

Dec 04, 2014, 06:00 ET

EMA approva la revisione del Riassunto delle Caratteristiche del Prodotto (RCP) Hizentra® di CSL Behring

-- Il nuovo RCP favorisce maggiore flessibilità e capacità di personalizzare il dosaggio  CSL Behring ha annunciato...

Dec 04, 2014, 06:00 ET

EMA erteilt Zulassung für aktualisierte Produktinformation für Hizentra® von CSL Behring

-- Neue Produktinformation unterstützt größere Flexibilität und die Möglichkeit zur individuellen Dosierung...

Dec 01, 2014, 11:00 ET

CMS Extends New Technology Add-On Payment for CSL Behring's Kcentra®

CSL Behring today announced that the Centers for Medicare and Medicaid Services (CMS) has extended the new technology add-on payment...

Nov 18, 2014, 10:00 ET

CSL112 Found to Elevate Cholesterol Efflux in Patients with Coronary Artery Disease and Mechanism for Rapid Cholesterol Efflux Capacity Demonstrated

Two research studies presented today at the American Heart Association Scientific Sessions in Chicago provide further understanding of the...